Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Proposes Registry On Thermal Ablation For Breast Cancer

This article was originally published in The Gray Sheet

Executive Summary

FDA says the development of a patient registry might help industry design better early-stage clinical trials for evaluating ablation as an alternative breast tumor treatment to more invasive surgery

You may also be interested in...



Consensus Elusive On Design Of Breast Cancer Ablation Registry

Cost and patient participation will probably be major impediments in developing a registry of breast cancer ablation clinical trials, according to stakeholder comments to FDA

Consensus Elusive On Design Of Breast Cancer Ablation Registry

Cost and patient participation will probably be major impediments in developing a registry of breast cancer ablation clinical trials, according to stakeholder comments to FDA

FDA Workshop Weighs Breast Cancer Ablation Benefits, Trial Protocol Issues

Stakeholders debating appropriate feasibility study protocol for image-guided thermal ablation of early-stage breast cancer are cautioning that increased use of advanced imaging for the procedures may counter some of the anticipated cost benefits

UsernamePublicRestriction

Register

MT026175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel